Rubicon Organics (ROMJF) announce the removal of all conditions precedent, related to its previously announced purchase and sale agreement with Medipharm Labs (MEDIF) for an operational, purpose-built 47,500 square foot indoor cultivation facility in Hope, British Columbia. This milestone clears the path for Rubicon Organics to finalize the acquisition of the Hope Facility, which is expected to significantly expand the Company’s premium production capacity and support its growth strategy. The Company expects to close the acquisition of the Hope Facility in the second quarter and will provide further updates as they become available.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ROMJF:
- Rubicon Organics to Announce Q1 2025 Financial Results
- Rubicon Organics Appoints Glen Ibbott as Interim CFO Amid Strategic Expansion
- Rubicon Organics appoints Glen Ibott as interim CFO
- Rubicon Organics Secures $4.5 Million in Private Placement to Boost Operations
- Rubicon Organics Expands Private Placement to Fuel Growth